Patent Assignment
Reel/Frame 056065/0276
Change of Name
Recorded: 2021-04-20
Pages: 4
Assignor
BOSTON BIOMEDICAL, INC.
Executed: 2020-07-01
Assignee
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 20, 2021
From: SIDDIQUI-JAIN, ADAM; FLYNN, PAUL; FUJIWARA, YUJI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 055969/0628 →
Assignment of Assignor's Interest
Apr 20, 2021
From: MASUMOTO, SHUJI; TANAKA, HIROAKI; KUREBAYASHI, HIROTAKA; HASHIZUKA, TAKAHIKO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 055970/0232 →
Assignment of Assignor's Interest
Apr 20, 2021
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 055970/0580 →
Merger
Apr 20, 2021
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 055970/0691 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →